On the prevalence of vernal keratoconjunctivitis and current possibilities of treatment

The importance of vernal keratoconjunctivitis (vernal conjunctivitis, or vernal catarrh) is not so much due to its level of prevalence (today its occurrence amounts to 1.25-11.29 per 10 000 population of European countries), but rather to the severity of its clinical course. Especially significant i...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Российский офтальмологический журнал
المؤلف الرئيسي:	V. V. Brzheskiy
التنسيق:	مقال
اللغة:	الروسية
منشور في:	Real Time Ltd 2018-10-01
الموضوعات:	весенний кератоконъюнктивит распространенность патогенез лечение vernal keratoconjunctivitis prevalence pathogenesis treatment
الوصول للمادة أونلاين:	https://roj.igb.ru/jour/article/view/126

مواد مشابهة

Vernal Keratoconjunctivitis Grading System and Step Ladder Management Approach
حسب: Nikhil S Gokhale
منشور في: (2014-10-01)

Immunopharmacology in Vernal Keratoconjunctivitis: Current and Future Perspectives
حسب: DeGaulle I. Chigbu, وآخرون
منشور في: (2021-07-01)

Vernal keratoconjunctivitis in Down syndrome: a case report
حسب: Maria Cristina Artesani, وآخرون
منشور في: (2023-03-01)

Conjunctival Cysts in a Case of Severe Vernal Keratoconjunctivitis – A Rare Finding
حسب: Rajwinder Kaur, وآخرون
منشور في: (2025-01-01)

A Study of Improvement in Quality of Life in Patients with Vernal Keratoconjunctivitis
حسب: Jagruti N Jadeja, وآخرون
منشور في: (2024-04-01)

An observational study on the presence of perilimbal conjunctival pigmentation in vernal keratoconjunctivitis
حسب: Srujana Dubbaka, وآخرون
منشور في: (2023-01-01)

Supratarsal injections versus topical steroids in resistant vernal keratoconjunctivitis
حسب: Nermeen M Badawi
منشور في: (2018-01-01)

Treatment of Corneal Lesions in Individuals with Vernal Keratoconjunctivitis
حسب: Naoki Kumagai, وآخرون
منشور في: (2005-01-01)

Comparative Efficacy and Safety of Topical Cyclosporine, Dexamethasone and Loteprednol in Vernal Keratoconjunctivitis
حسب: Muhammad Shahid Naeem, وآخرون
منشور في: (2024-12-01)

Comparative Efficacy and Safety of Topical Cyclosporine, Dexamethasone and Loteprednol in Vernal Keratoconjunctivitis
حسب: Muhammad Shahid Naeem, وآخرون
منشور في: (2024-12-01)

Understanding vernal keratoconjunctivitis in children
حسب: Hlupheka L. Sithole
منشور في: (2020-09-01)

Vernal Keratoconjunctivitis: an update focused on clinical grading system
حسب: A. M. Zicari, وآخرون
منشور في: (2019-05-01)

Vernal keratoconjunctivitis in adults: a narrative review of prevalence, pathogenesis, and management
حسب: Antonio Di Zazzo, وآخرون
منشور في: (2024-02-01)

Vernal keratoconjunctivitis: Current immunological and clinical evidence and the potential role of omalizumab
حسب: Serge Doan, MD, وآخرون
منشور في: (2023-06-01)

Low dose Mitomycin-C in severe vernal keratoconjunctivitis: A randomized prospective double blind study
حسب: Jain Arun, وآخرون
منشور في: (2006-01-01)

The damaging shield: An incapacitating presentation of vernal keratoconjunctivitis
حسب: Mamta Agrawal, وآخرون
منشور في: (2021-01-01)

Ocular surface squamous neoplasia masquerading as pseudoepitheliomatous hyperplasia in chronic vernal keratoconjunctivitis
حسب: Ghosh Dastidar, Aditi, وآخرون
منشور في: (2024-01-01)

Classification of Subtypes of Vernal Keratoconjunctivitis by Cluster Analysis Based on Clinical Features
حسب: Fujita H, وآخرون
منشور في: (2023-10-01)

Association of Vernal Keratoconjunctivitis (VKC) with Keratoconus in Patients Presenting to Ophthalmology Clinics of Rawal Institute of Health Sciences, Pakistan
حسب: Maham Zehra, وآخرون
منشور في: (2024-04-01)

The Efficacy of Topical 0.03% Tacrolimus Dermatologic Ointment in Treatment of Vernal Keratoconjunctivitis
حسب: Muhammad Adnan, وآخرون
منشور في: (2021-09-01)

Long-term efficacy of omalizumab in patients with conventional treatment-resistant vernal keratoconjunctivitis
حسب: Luis Santamaria, وآخرون
منشور في: (2018-07-01)

Clinical pattern of vernal keratoconjunctivitis in children – A cross-sectional study
حسب: Roopa K, وآخرون
منشور في: (2024-07-01)

To evaluate the effects of the application of 0.03% tacrolimus ointment in patients of vernal keratoconjunctivitis at a tertiary care hospital
حسب: Ajay V. Waghmare, وآخرون
منشور في: (2024-09-01)

Demographic And Clinical Features Of Vernal Keratoconjunctivitis in a Hot Region: A Hospital-Based Study
حسب: Seyfettin Erdem
منشور في: (2019-10-01)

Clinical Outcomes of Topical 0.1% Ciclosporin Cationic Emulsion Used on Label in Children with Vernal Keratoconjunctivitis
حسب: Giuseppe Giannaccare, وآخرون
منشور في: (2023-04-01)

Response of Autologous Serum Supratarsal Injection in Patients of Vernal Keratoconjunctivitis in Longterm Followup
حسب: Ritu Agarwal, وآخرون
منشور في: (2019-10-01)

Vernal keratoconjunctivitis and eosinophilic esophagitis: A rare combination?
حسب: Maria Cristina Artesani, MD, وآخرون
منشور في: (2024-01-01)

The impact of tacrolimus therapy on the outcomes of vernal keratoconjunctivitis: a systematic review and meta-analysis
حسب: Reem AlHuthail
منشور في: (2025-07-01)

Understanding Vernal Keratoconjunctivitis: Beyond Allergic Mechanisms
حسب: Marta Sacchetti, وآخرون
منشور في: (2021-09-01)

Vernal keratoconjunctivitis in human immunodeficiency positives: A case series
حسب: Shweta Agarwal, وآخرون
منشور في: (2025-04-01)

The Safety and Effectiveness of 0.03% Tacrolimus in Pediatric Patients Presenting with Vernal Keratoconjunctivitis in Children Hospital, Multan
حسب: Muhammad Ajmal Chaudhary, وآخرون
منشور في: (2025-01-01)

Vernal Keratoconjunctivitis among Patients Presenting to the Outpatient Department of Ophthalmology of a Tertiary Care Centre: A Descriptive Cross-sectional Study
حسب: Neha Priyadarshani Chaudhary, وآخرون
منشور في: (2023-01-01)

Rebamipide 2% Ophthalmic Suspension for the Treatment of Allergic Keratoconjunctivitis: A Hospital Based Study
حسب: Munish Dhawan, وآخرون
منشور في: (2016-04-01)

Cyclosporine A and autologous serum efficacy for treatment of vernal keratoconjunctivitis
حسب: Ahmed Esmail, وآخرون
منشور في: (2024-05-01)

Prevalence and risk factors of Vernal Keratoconjunctivitis among a Ghanaian clinical cohort: A case‐control study
حسب: Samuel Kyei, وآخرون
منشور في: (2024-03-01)

Vernal keratoconjunctivitis: The burden of being allergic
حسب: Maria Cristina Artesani, MD, وآخرون
منشور في: (2025-05-01)

Long-term use of 0.003% tacrolimus suspension for treatment of vernal keratoconjunctivitis
حسب: Abdulrahman Mohammed Al-Amri, وآخرون
منشور في: (2017-01-01)

The effect of COVID-19 imposed lockdown on Italian children with Vernal Keratoconjunctivitis
حسب: Artesani Maria Cristina, MD, وآخرون
منشور في: (2022-10-01)

Reserve drug as first-line management: Topical interferon α-2b for vernal keratoconjunctivitis
حسب: Saurabh Ramdas Haral, وآخرون
منشور في: (2024-03-01)

Serum vitamin D levels in children with vernal keratoconjunctivitis – A study from a tertiary care pediatric hospital of North India
حسب: Meenakshi Wadhwani, وآخرون
منشور في: (2024-05-01)